Results from the US Food and Drug Administration’s and manufacturers’ responses this year to an infant formula shortage pointed the agency to plan to streamline its procedures for allowing additional firms to market formula.
The agency on 6 July announced it has “determined that a more streamlined pathway” using information it has received for formula products available under a temporary guidance for enforcement discretion published in May “would help
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?